BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28724361)

  • 21. Plasma brain-derived neurotrophic factor levels after severe traumatic brain injury.
    Simon D; Nascimento RI; Filho EM; Bencke J; Regner A
    Brain Inj; 2016; 30(1):23-8. PubMed ID: 26555864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    World Neurosurg; 2019 Dec; 132():e613-e617. PubMed ID: 31442647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
    Lorente L; Martín MM; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; Borreguero-León JM
    PLoS One; 2015; 10(3):e0121739. PubMed ID: 25822281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury.
    Li M; Jia Q; Chen T; Zhao Z; Chen J; Zhang J
    Clin Neurol Neurosurg; 2016 May; 144():7-13. PubMed ID: 26945876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between serum fibrinogen-like protein 2 concentrations and 30-day mortality of patients with traumatic brain injury.
    Chen TJ; Ji MX; Tao ZQ; Fu QY; Xiong K; Cheng B
    Clin Chim Acta; 2019 Feb; 489():53-57. PubMed ID: 30503273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients.
    Albert V; Subramanian A; Agrawal D; Bhoi SK; Pallavi P; Mukhopadhayay AK
    BMC Res Notes; 2017 Mar; 10(1):139. PubMed ID: 28340601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels.
    Gullo Jda S; Bertotti MM; Silva CC; Schwarzbold M; Diaz AP; Soares FM; Freitas FC; Nunes J; Pinheiro JT; Morato EF; Prediger RD; Linhares MN; Walz R
    Neurocrit Care; 2011 Apr; 14(2):194-9. PubMed ID: 20972645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traumatic Brain Injury Patients Mortality and Serum Total Antioxidant Capacity.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Abreu-González P; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32085496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of long-term (median 10.5 years) outcomes in children presenting with traumatic brain injury and an initial Glasgow Coma Scale score of 3 or 4.
    Fulkerson DH; White IK; Rees JM; Baumanis MM; Smith JL; Ackerman LL; Boaz JC; Luerssen TG
    J Neurosurg Pediatr; 2015 Oct; 16(4):410-9. PubMed ID: 26140392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum periostin concentrations and outcomes after severe traumatic brain injury.
    Dong XQ; Yu WH; Du Q; Wang H; Zhu Q; Yang DB; Che ZH; Shen YF; Jiang L
    Clin Chim Acta; 2017 Aug; 471():298-303. PubMed ID: 28668564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin secretion after head injury: a pilot study.
    Paparrigopoulos T; Melissaki A; Tsekou H; Efthymiou A; Kribeni G; Baziotis N; Geronikola X
    Brain Inj; 2006 Jul; 20(8):873-8. PubMed ID: 17060154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis.
    Schneider Soares FM; Menezes de Souza N; Libório Schwarzbold M; Paim Diaz A; Costa Nunes J; Hohl A; Nunes Abreu da Silva P; Vieira J; Lisboa de Souza R; Moré Bertotti M; Schoder Prediger RD; Neves Linhares M; Bafica A; Walz R
    Neuroimmunomodulation; 2012; 19(6):377-85. PubMed ID: 23075771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glasgow Coma Scale Score in Survivors of Explosion With Possible Traumatic Brain Injury in Need of Neurosurgical Intervention.
    Ashkenazi I; Schecter WP; Peleg K; Givon A; Olsha O; Turegano-Fuentes F; Alfici R; ; Bahouth H; Becker A; Ben Ely M; Braslavsky A; Jeroukhimov I; Qarawany M; Kessel B; Klein Y; Lin G; Merin O; Bala M; Mnouskin Y; Rivkind AI; Shaked G; Soffer D; Stein M; Weiss M
    JAMA Surg; 2016 Oct; 151(10):954-958. PubMed ID: 27409973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality.
    Lorente L; Martín MM; Abreu-González P; Ramos L; Argueso M; Solé-Violán J; Riaño-Ruiz M; Jiménez A
    PLoS One; 2015; 10(5):e0125893. PubMed ID: 25933254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of serum tissue kallikrein levels after traumatic brain injury.
    Huang JJ; Qiu SZ; Zheng GR; Chen B; Shen J; Yin HM; Mao W
    Clin Chim Acta; 2019 Dec; 499():93-97. PubMed ID: 31499021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
    Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
    J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moderate and severe traumatic brain injury: effect of blood alcohol concentration on Glasgow Coma Scale score and relation to computed tomography findings.
    Rundhaug NP; Moen KG; Skandsen T; Schirmer-Mikalsen K; Lund SB; Hara S; Vik A
    J Neurosurg; 2015 Jan; 122(1):211-8. PubMed ID: 25361494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.